Symbiox Investment Peer Comparison
BSE: 539278
₹1.58
As on 09-Nov-2026IST
Market cap
₹5 Cr
Revenue (TTM)
₹1 Cr
P/E Ratio
30.3
P/B Ratio
0.2
Div. Yield
0 %
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
5 | 15,629 | 2,535 | 2,000 | 1,502 |
Revenue (₹ Cr) |
1 | 1,880 | 98 | 193 | 44 |
Net Profit (₹ Cr) |
0.16 | 403.55 | 56.60 | 155.78 | 4.63 |
Net Margin (%) |
11.64 | 19.94 | 57.48 | 80.24 | 10.45 |
RoE (%) |
0.51 | 16.40 | 0.35 | 1.70 | 17.49 |
Price to Earnings |
30.33 | 39.06 | 45.77 | 12.84 | 331.51 |
Price-To-Book |
0.15 | 6.23 | 0.17 | 0.21 | 53.98 |
Income Statement (₹ Cr)
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
|
Operating Revenue
|
1.40 | 1,880.41 | 98.44 | 192.64 | 44.16 |
|
Total Income
|
1.40 | 2,024.21 | 98.46 | 194.14 | 44.27 |
|
Total Expenditure
|
1.18 | 1,425.87 | 21.79 | 5.79 | 35.06 |
|
EBITDA
|
0.22 | 454.54 | 76.65 | 186.85 | 9.10 |
|
Depreciation
|
0.00 | 56.75 | 0.02 | 1.43 | 0.56 |
|
EBIT
|
0.22 | 397.79 | 76.63 | 185.42 | 8.54 |
|
Interest
|
0.00 | 7.03 | 0.41 | 0.00 | 0.34 |
|
Other Income
|
0.00 | 143.80 | 0.02 | 1.50 | 0.10 |
|
Exceptional Items
|
0.00 | 0.00 | -0.02 | 0.00 | 0.00 |
|
Profit before Tax
|
0.22 | 534.57 | 76.23 | 186.92 | 8.31 |
|
Provision for Tax
|
0.06 | 131.01 | 19.63 | 31.14 | 3.68 |
|
Profit after Tax
|
0.16 | 403.55 | 56.60 | 155.78 | 4.63 |
Liabilities (₹ Cr)
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
31.88 | 2,509.96 | 15,173.05 | 9,648.87 | 27.27 |
|
Minority Interest
|
0.00 | -0.62 | -2.21 | 0.00 | -0.10 |
|
Non-Current Liabilities
|
0.00 | 45.65 | 1,957.69 | 1,485.83 | 1.30 |
|
Current Liabilities
|
0.10 | 1,741.42 | 7.32 | 0.10 | 29.52 |
|
Total Liabilities
|
32.01 | 2,984.84 | 18,946.98 | 10,734.37 | -- |
Assets (₹ Cr)
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
0.01 | 2,087.94 | 0.02 | 39.05 | 2.29 |
|
Current Assets
|
31.96 | 2,115.17 | 17,184.45 | 11,095.28 | 55.27 |
|
Total Assets
|
32.01 | 2,984.84 | 18,946.98 | 10,734.37 | -- |
|
Total Debt*
|
0.00 | 0.00 | 0.00 | 0.00 | -- |
|
Net Current Assets
|
31.86 | 373.75 | 17,177.13 | 11,095.18 | 25.75 |
|
Contingent Liabilities
|
-- | 1,529.63 | 17.98 | -- | -- |
Cashflow (₹ Cr)
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
3.58 | 563.34 | 61.71 | 94.10 | -- |
|
Cash Flow from Investing Activities
|
-2.84 | -502.32 | -75.37 | -95.00 | -- |
|
Cash from Financing Activities
|
-- | -21.87 | -0.03 | -0.50 | -- |
|
Net Cash Inflow / Outflow
|
0.75 | 39.15 | -13.68 | -1.40 | -- |
Ratios
Profitability Ratios
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
|
ROCE (%)
|
0.82 | 24.80 | 0.44 | 1.98 | -- |
|
ROE (%)
|
0.51 | 16.40 | 0.35 | 1.70 | 17.49 |
|
ROA (%)
|
0.51 | 9.95 | 0.31 | 1.42 | 9.97 |
|
EBIT Margin (%)
|
15.64 | 21.15 | 77.84 | 96.25 | 19.35 |
|
Net Margin (%)
|
11.64 | 19.94 | 57.48 | 80.24 | 10.45 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-51.89 | 30.74 | -19.75 | 70.16 | 20.50 |
|
EBIT Growth (%)
|
-35.01 | 8.94 | 32.48 | 75.73 | -27.53 |
|
Net Profit Growth (%)
|
-35.57 | 9.24 | 36.43 | 105.15 | -54.49 |
|
EPS Growth (%)
|
-35.57 | 8.40 | 27.81 | 105.15 | -74.69 |
|
Book Value Growth (%)
|
0.61 | 19.07 | 32.35 | -21.53 | -- |
Valuation Ratios
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
|
Price / Earnings
|
30.33 | 39.06 | 45.76 | 17.34 | 331.73 |
|
Price / Book Value
|
0.15 | 6.23 | 0.17 | 0.29 | 53.98 |
|
Dividend Yield (%)
|
0.00 | 0.51 | 0.00 | 0.02 | 0.05 |
|
EV/EBITDA
|
-39.60 | 30.76 | 30.53 | 12.79 | 166.97 |
|
Market Cap (₹ Cr)
|
9.98 | 0.00 | 3,112.75 | 2,652.46 | -- |
Solvency Ratios
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
|
Short term debt to equity ratio
|
-- | -- | 0.00 | -- | -- |
|
Current Ratio
|
319.64 | 1.21 | 2,348.24 | 1,07,721.20 | 1.87 |
|
Quick Ratio
|
313.30 | 1.21 | 2,348.24 | 1,07,721.20 | 0.71 |
|
Interest Coverage
|
564.45 | 77.06 | 186.46 | -- | 25.36 |
Operating Efficiency Ratios
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
20.43 | 13.52 | 4.88 | -- | 16.30 |
|
Asset Turnover
|
0.04 | 0.46 | 0.01 | 0.02 | 0.95 |
|
Receivable days
|
11.33 | 27.39 | 1.52 | 0.00 | -- |
|
Inventory Days
|
91.53 | 0.00 | 99.79 | 0.00 | -- |
|
Payable days
|
30.52 | -- | 11.82 | -- | -- |
|
Cash Conversion Cycle
|
72.34 | -- | 89.49 | -- | -- |